Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications
about
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerIdentification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new eraThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careGenetics and biological markers in urachal cancerRole of Deficient Mismatch Repair in the Personalized Management of Colorectal CancerColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachMolecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic studySimplified microsatellite instability detection protocol provides equivalent sensitivity to robust detection strategies in Lynch syndrome patients.Incomplete Segregation of MSH6 Frameshift Variants with Phenotype of Lynch Syndrome.Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers.ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.Prevalence and implications of elevated microsatellite alterations at selected tetranucleotides in cancer.Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transitionColorectal carcinoma: Pathologic aspectsMolecular markers identify subtypes of stage III colon cancer associated with patient outcomesA novel approach for characterizing microsatellite instability in cancer cells.Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers.Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.Adaptive clinical trial designs in oncology.Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.An Integrative Approach for Mapping Differentially Expressed Genes and Network Components Using Novel Parameters to Elucidate Key Regulatory Genes in Colorectal Cancer.Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancerHow many diseases are colorectal cancer?Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)Colorectal Cancer: Personalized Therapy.Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer.CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.Microsatellite alteration in head and neck squamous cell carcinoma patients from a betel quid-prevalent regionDifferential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapyMolecular Biomarkers in the Personalized Treatment of Colorectal Cancer.Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancersHereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic targetAlterations of microsatellite loci GSN and D18S51 in urinary bladder cancerElevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?The role of personalized medicine in metastatic colorectal cancer: an evolving landscape.Molecular pathways involved in colorectal cancer: implications for disease behavior and preventionMolecular correlates and prognostic value of tmTNF-α expression in colorectal cancer of 5-Fluorouracil-Based Adjuvant TherapyMicrosatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study.Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer.
P2860
Q26766285-1B758EF4-774C-4453-8360-73D6D6D32B05Q27693248-2EE7877C-223E-4D67-BCA7-6236719EA1A9Q28066460-769CC918-78D6-4930-A97F-1527B2677EBDQ28069688-4EAEC086-C4FB-451F-A997-6FF2D94EECDAQ28080176-6E72B03B-E69E-4323-A0F5-B7BFA6FDFCD7Q28647615-4001C85A-0179-4625-BC5A-7E350EE1D380Q33682949-05560E4C-BF34-4AE5-8893-695837E41FCFQ33728916-D86949B0-C76B-46FB-854C-237C7D57B159Q33755092-A249E259-0EA4-490D-8E34-BA45C808B402Q33765195-FE16954B-507A-4E86-A4A3-6A214DAD6EEDQ33779292-8F02A89B-9E3A-4882-AA26-ABD1577595CBQ34113455-0D0849E1-C7ED-42FB-A121-A1B307F67B5AQ34522228-EAEBD1C6-9DE1-4EFB-9561-17C52FB737BEQ34642007-54C6CC0A-ECAC-49A7-8A29-259210869AD1Q34665492-14CE9D39-EEF6-4F4B-BF9F-06FEB6E1FC02Q34720965-5231DA34-EB0A-447E-A4F4-BEB393BB80BDQ35067307-A066DFF3-E5E4-4A7D-9D0B-B9F152D173BDQ35130874-935BF828-2250-41CC-B5C5-774633AF5FD3Q35181103-EF84C21E-6018-4124-9CC3-A8F01E6DE16DQ35206844-A180C0B1-0E49-45D4-9355-EB9AE446F31DQ35652713-8318021C-0158-4471-9A4F-8258F562BC8DQ35723844-9EDE6548-9FC1-4BA7-8DBD-0723778FD11FQ36081402-FF8CBA17-6947-4097-9448-51D230DD6491Q36238965-B3226705-FD9F-478C-8DA4-AACA11425734Q36342900-476AF883-209B-4A96-9C6B-C09FED3B627EQ36344547-AEB99529-0E8E-4141-A7AC-B02AEC83334DQ36412420-5BF9EEAB-1F90-4E58-B8A9-59167C9AD2A4Q36544662-BC35B7E6-DBBE-4C0C-BF86-B7659A5EC327Q36724828-ADB377B7-C9AE-456B-8E67-DB2A83A75E59Q36768782-339D5AE9-7B5A-4A3E-BD75-C04184A1DC6FQ36813582-4CDE857A-3EEF-48A7-A565-68575DE718E5Q36889627-0A4447A8-074A-4DF7-8B75-40F182494BF4Q36990060-CB9B6925-355B-4619-929D-F57FE236712AQ37079293-4718D0B1-A070-4675-80EF-1B55B68AC021Q37094934-82869E89-698E-4674-AA0D-31D4E9CACF4EQ37130603-45773FCC-00CE-48D8-98F5-694C56AA2D97Q37139174-27CE452B-D232-455F-BAEA-FA2D4BC5709FQ37187787-8B60D6BD-3AF1-43BC-AD2E-B38DD065FAD1Q37269648-B4B1DF05-AFDE-4256-A069-4437EC115881Q37343279-C8211F61-558E-41BD-997C-5CAA9DFCF733
P2860
Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Molecular pathways: microsatel ...... , and therapeutic implications
@ast
Molecular pathways: microsatel ...... , and therapeutic implications
@en
type
label
Molecular pathways: microsatel ...... , and therapeutic implications
@ast
Molecular pathways: microsatel ...... , and therapeutic implications
@en
prefLabel
Molecular pathways: microsatel ...... , and therapeutic implications
@ast
Molecular pathways: microsatel ...... , and therapeutic implications
@en
P2860
P1476
Molecular pathways: microsatel ...... , and therapeutic implications
@en
P2093
Frank A Sinicrope
P2860
P304
P356
10.1158/1078-0432.CCR-11-1469
P407
P577
2012-02-02T00:00:00Z